Skip to main content

Hepatic Encephalopathy News

Low Zinc Levels Seen With Liver Cirrhosis, Hepatic Encephalopathy

WEDNESDAY, Nov. 6, 2024 – Serum zinc is often deficient in patients with liver cirrhosis and hepatic encephalopathy (HE), according to a study published online in the September issue of the Journal...

Automated Speech Analysis Correlates With Hepatic Encephalopathy Tests

TUESDAY, Oct. 8, 2024 – Automated speech analysis correlates with validated hepatic encephalopathy (HE) tests and may predict future overt HE, according to a study published online Sept. 12 in...

FDA Approves New Use of Xifaxan for Patients with Liver Disease

SILVER SPRING, Md., March 24 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved the use of Xifaxan for reduction in the risk of the recurrence of overt hepatic...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

lactulose, Xifaxan, neomycin